Liver transplantation is the gold standard of care in patients with end-stage liver disease and
those with tumors of hepatic origin in the setting of liver dysfunction. From 1988 to 2009, liver …

Despite the increase in long-term survival, liver transplant recipients still exhibit higher
morbidity and mortality than the general population. This is in part attributed to the lifelong …

Eighty-four HCV/HIV-coinfected and 252-matched HCV-monoinfected liver transplant
recipients were included in a prospective multicenter study. Thirty-six (43%) HCV/HIV …

With improved long-term survival following liver transplantation (LT), issues relating to the
assessment of the liver allograft in long-term survivors are becoming increasingly relevant …

BACKGROUND & AIMS: Recurrence of chronic hepatitis C and progressive fibrosis in liver
transplants is frequent and impairs both graft and patient survival. Whether or not the choice …

This article focuses on the main patterns of damage that are seen in liver allograft biopsies.
As with the interpretation of liver biopsies from the native liver, clinicopathological correlation …

Our aim was to assess long‐term survival in patients transplanted for HCV‐related end‐
stage liver disease (ESLD) and evaluate potentially modifiable predictors of survival. We …

Survival following liver transplantation has changed dramatically owing to improvement in
surgical techniques, peri-operative care and optimal immunosuppressive therapy. Post-Liver …

HCV related liver disease is the most common indication for liver transplantation.
Recurrence of HCV infection is universal and has a substantial impact on patient and graft …

Achieving optimum outcomes after liver transplantation requires an understanding of the
interaction between donor, graft and recipient factors. Within the cohort of patients waiting for …